Concepedia

Tadakatsu Nakamura

TN

Statistics

Publications

3

Citations

235

H-Index

3

Active since

2016

Affiliations

Mitsubishi Group (Japan)(Current)

Mitsubishi Tanabe Pharma Corporation

Tadakatsu Nakamura is an author at Mitsubishi Group (Japan) specializing in molecular pharmacology, schizophrenia, and mood disorders.

Top concepts

Publications per year

2016–2024

3

Publications

3

Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study

Aditya Bardia, Ian E. Krop, Takahiro Kogawa et al. · Journal of Clinical Oncology · 2024 · 124 citations · Full text

Clinical pharmacology study of cariprazine (MP-214) in patients with schizophrenia (12-week treatment)

Tadakatsu Nakamura, Tomoko Kubota, Atsushi Iwakaji et al. · Drug Design Development and Therapy · 2016 · 88 citations · Full text

, , +16

Phase 1 Studies to Define the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone in Healthy Volunteers

Tadakatsu Nakamura, Atsuhiro Kawaguchi · Clinical Pharmacology in Drug Development · 2020 · 23 citations · Full text

1–3 of 3